TGen News & Press Releases : TD2 and Critical Outcome Technologies Inc. develop novel anti-cancer drug
Main Image

National Postdoc Appreciation Week 2018 - Dr. Elizabeth Raupach

Dr. Elizabeth Raupach is a postdoc in the Will Hendricks Lab at TGen where she studies ovarian cancer.

Dr. Elizabeth Raupach is a postdoc in the Will Hendricks Lab in the Integrated Cancer Genomics Division at TGen. She studies ovarian cancer. She answered Three Burning Questions for us in honor of National Postdoc Appreciation Week 2018:

  1. What is the best thing about being a postdoc at TGen? People are actually nice here and collaborate well instead of trying to compete with each other.  TGen does team science better than anywhere else that I've worked.  As Dr. Trent puts it, "the only competition is cancer," which is exactly how it should be.
  2. What is the most interesting aspect of your role/job? As a postdoc I find the most interesting part of the job, as compared to my previous positions, is that I have more license and freedom to think and choose and develop my own ideas and plans for what to do in my research.
  3. How did you get into science? An accident really.  I started studying science because it was the first thing that really challenged me, and I had to work hard and really think about things.  Science was like a really fun puzzle.


Media Contact

Blog Archive